\relax 
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand\HyField@AuxAddToFields[1]{}
\providecommand\HyField@AuxAddToCoFields[2]{}
\providecommand \oddpage@label [2]{}
\babel@aux{english}{}
\@writefile{toc}{\contentsline {chapter}{\numberline {1}Transcription}{6}{chapter.1}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {1.1}Transcription initiation}{6}{section.1.1}\protected@file@percent }
\newlabel{transcription-initiation}{{1.1}{6}{Transcription initiation}{section.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.1}{\ignorespaces Sainsbury et al., Nature Review Mol. Cell. Biol. 2015\relax }}{6}{figure.caption.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.2}{\ignorespaces Sainsbury et al., Nature Review Mol. Cell. Biol. 2015\relax }}{7}{figure.caption.3}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {1.2}Chromatin remodeling}{8}{section.1.2}\protected@file@percent }
\newlabel{chromatin-remodeling}{{1.2}{8}{Chromatin remodeling}{section.1.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.2.0.1}Techniques to study chromatin remodelling}{8}{subsubsection.1.2.0.1}\protected@file@percent }
\newlabel{techniques-to-study-chromatin-remodelling}{{1.2.0.1}{8}{Techniques to study chromatin remodelling}{subsubsection.1.2.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.3}{\ignorespaces Nucleosome occupancy\relax }}{9}{figure.caption.4}\protected@file@percent }
\providecommand*\caption@xref[2]{\@setref\relax\@undefined{#1}}
\newlabel{fig:nucleosome}{{1.3}{9}{Nucleosome occupancy\relax }{figure.caption.4}{}}
\@writefile{toc}{\contentsline {section}{\numberline {1.3}Nucleosome organization}{9}{section.1.3}\protected@file@percent }
\newlabel{nucleosome-organization}{{1.3}{9}{Nucleosome organization}{section.1.3}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3.1}Nucleosome remodelling}{9}{subsection.1.3.1}\protected@file@percent }
\newlabel{nucleosome-remodelling}{{1.3.1}{9}{Nucleosome remodelling}{subsection.1.3.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.4}{\ignorespaces Becker and Workman, Cold Spring Harbor Laboratory, 2013\relax }}{10}{figure.caption.5}\protected@file@percent }
\newlabel{fig:peeling}{{1.4}{10}{Becker and Workman, Cold Spring Harbor Laboratory, 2013\relax }{figure.caption.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.5}{\ignorespaces Venkatesh and Workman, Nature Rev Mol Cell Biol, 2015\relax }}{10}{figure.caption.6}\protected@file@percent }
\newlabel{fig:pronucleo}{{1.5}{10}{Venkatesh and Workman, Nature Rev Mol Cell Biol, 2015\relax }{figure.caption.6}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.6}{\ignorespaces Cross linking\relax }}{11}{figure.caption.7}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3.2}Chromatin Immunoprecipitation}{11}{subsection.1.3.2}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3.3}Main nucleosome modifications in promoters}{11}{subsection.1.3.3}\protected@file@percent }
\newlabel{main-nucleosome-modifications-in-promoters}{{1.3.3}{11}{Main nucleosome modifications in promoters}{subsection.1.3.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.7}{\ignorespaces Guenther et al., Cell 2007\relax }}{12}{figure.caption.8}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3.4}RT-qPCR based detection of 5' RNA transcripts of inactive genes}{12}{subsection.1.3.4}\protected@file@percent }
\newlabel{rt-qpcr-based-detection-of-5-rna-transcripts-of-inactive-genes}{{1.3.4}{12}{RT-qPCR based detection of 5' RNA transcripts of inactive genes}{subsection.1.3.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.8}{\ignorespaces Core et al, 2008\relax }}{13}{figure.caption.9}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.9}{\ignorespaces Differential phosphorylation of RNA Pol II CTD during transcription.\relax }}{13}{figure.caption.10}\protected@file@percent }
\newlabel{fig:phCTD}{{1.9}{13}{Differential phosphorylation of RNA Pol II CTD during transcription.\relax }{figure.caption.10}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3.5}Global run-on sequencing (GRO-seq)}{13}{subsection.1.3.5}\protected@file@percent }
\newlabel{global-run-on-sequencing-gro-seq}{{1.3.5}{13}{Global run-on sequencing (GRO-seq)}{subsection.1.3.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.10}{\ignorespaces Jonkers \& Lis, Nature Rev Mol Cell Biol, 2015\relax }}{14}{figure.caption.11}\protected@file@percent }
\newlabel{fig:dsif}{{1.10}{14}{Jonkers \& Lis, Nature Rev Mol Cell Biol, 2015\relax }{figure.caption.11}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3.6}Transcription pausing mechanism}{14}{subsection.1.3.6}\protected@file@percent }
\newlabel{transcription-pausing-mechanism}{{1.3.6}{14}{Transcription pausing mechanism}{subsection.1.3.6}{}}
\@writefile{toc}{\contentsline {section}{\numberline {1.4}Transcription elongation}{15}{section.1.4}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.4.1}Structural basis of the nucleosome transition during RNA pol II passage}{15}{subsection.1.4.1}\protected@file@percent }
\newlabel{structural-basis-of-the-nucleosome-transition-during-rna-pol-ii-passage---kujirai-et-al-2018}{{1.4.1}{15}{Structural basis of the nucleosome transition during RNA pol II passage}{subsection.1.4.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.1}Nucleosome structure}{15}{subsubsection.1.4.1.1}\protected@file@percent }
\newlabel{nucleosome-structure}{{1.4.1.1}{15}{Nucleosome structure}{subsubsection.1.4.1.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.2}Cryo-EM}{15}{subsubsection.1.4.1.2}\protected@file@percent }
\newlabel{cryo-em}{{1.4.1.2}{15}{Cryo-EM}{subsubsection.1.4.1.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.11}{\ignorespaces Kujirai and Kurumizaka, \emph  {Curr Op. Struct. Biol.,} 2020\relax }}{16}{figure.caption.12}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.12}{\ignorespaces Screenshot 2022-10-05 at 22.57.06.png\relax }}{16}{figure.caption.13}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.13}{\ignorespaces Kujirai at al., \emph  {Science,} 2018\relax }}{16}{figure.caption.14}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.14}{\ignorespaces Screenshot 2022-10-05 at 23.02.04.png\relax }}{17}{figure.caption.15}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.15}{\ignorespaces Kujirai and Kurumizaka., \emph  {Curr Op. Struct. Biol.,} 2020\relax }}{17}{figure.caption.16}\protected@file@percent }
\newlabel{fig:looping}{{1.15}{17}{Kujirai and Kurumizaka., \emph {Curr Op. Struct. Biol.,} 2020\relax }{figure.caption.16}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.3}Summary of the main results}{17}{subsubsection.1.4.1.3}\protected@file@percent }
\newlabel{summary-of-the-main-results}{{1.4.1.3}{17}{Summary of the main results}{subsubsection.1.4.1.3}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.4.2}Template looping}{17}{subsection.1.4.2}\protected@file@percent }
\newlabel{template-looping}{{1.4.2}{17}{Template looping}{subsection.1.4.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.16}{\ignorespaces Lai and Pugh, \emph  {Nature Review Mol Cell Biol}. 2017\relax }}{18}{figure.caption.17}\protected@file@percent }
\newlabel{fig:FACT}{{1.16}{18}{Lai and Pugh, \emph {Nature Review Mol Cell Biol}. 2017\relax }{figure.caption.17}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.17}{\ignorespaces Van Oss \emph  {et al., TRENDS Biochem Sci.} 2017\relax }}{18}{figure.caption.18}\protected@file@percent }
\newlabel{fig:el}{{1.17}{18}{Van Oss \emph {et al., TRENDS Biochem Sci.} 2017\relax }{figure.caption.18}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.4.3}Structural basis of nucleosome disassembly and reassembly by RNA P II elongation complex with FACT}{18}{subsection.1.4.3}\protected@file@percent }
\newlabel{structural-basis-of-nucleosome-disassembly-and-reassembly-by-rna-p-ii-elongation-complex-with-fact---ehara-et-al.}{{1.4.3}{18}{Structural basis of nucleosome disassembly and reassembly by RNA P II elongation complex with FACT}{subsection.1.4.3}{}}
\@writefile{toc}{\contentsline {section}{\numberline {1.5}Transcription termination}{18}{section.1.5}\protected@file@percent }
\newlabel{termination}{{1.5}{18}{Transcription termination}{section.1.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.18}{\ignorespaces \relax }}{19}{figure.caption.19}\protected@file@percent }
\newlabel{fig:exp}{{1.18}{19}{\relax }{figure.caption.19}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.19}{\ignorespaces Porrua \& Libri, Nature Review Mol Cell Biol, 2015\relax }}{19}{figure.caption.20}\protected@file@percent }
\newlabel{fig:torpedo}{{1.19}{19}{Porrua \& Libri, Nature Review Mol Cell Biol, 2015\relax }{figure.caption.20}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.5.1}Promoter reporter assay}{19}{subsection.1.5.1}\protected@file@percent }
\newlabel{promoter-reporter-assay}{{1.5.1}{19}{Promoter reporter assay}{subsection.1.5.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.20}{\ignorespaces Anderson \& Sandelin, \emph  {Nature Review Gen}. 2019\relax }}{20}{figure.caption.21}\protected@file@percent }
\newlabel{fig:passay}{{1.20}{20}{Anderson \& Sandelin, \emph {Nature Review Gen}. 2019\relax }{figure.caption.21}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.5.2}Promoter types}{20}{subsection.1.5.2}\protected@file@percent }
\newlabel{promoter-types}{{1.5.2}{20}{Promoter types}{subsection.1.5.2}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.5.3}Transcription factor binding}{20}{subsection.1.5.3}\protected@file@percent }
\newlabel{transcription-factor-binding}{{1.5.3}{20}{Transcription factor binding}{subsection.1.5.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.21}{\ignorespaces Lenhard \emph  {et al., Nature Rev Cancer} 2012\relax }}{21}{figure.caption.22}\protected@file@percent }
\newlabel{fig:types}{{1.21}{21}{Lenhard \emph {et al., Nature Rev Cancer} 2012\relax }{figure.caption.22}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.22}{\ignorespaces Haberle \& Stark, \emph  {NatRevMolCelBiol.} 2018\relax }}{21}{figure.caption.22}\protected@file@percent }
\newlabel{fig:burst}{{1.22}{21}{Haberle \& Stark, \emph {NatRevMolCelBiol.} 2018\relax }{figure.caption.22}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {2}Transcription regulation and its deregulation in cancer}{22}{chapter.2}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {2.1}Mediator complex}{22}{section.2.1}\protected@file@percent }
\newlabel{mediator-complex}{{2.1}{22}{Mediator complex}{section.2.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.1}{\ignorespaces The Mediator acts as a hub integrating signals from multiple pathways\relax }}{22}{figure.caption.23}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.2}{\ignorespaces Allen and Taatjes \emph  {, Nature Review Mol Cell Biol.}2015\relax }}{23}{figure.caption.24}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.3}{\ignorespaces Soutourina\emph  {, Nature Review Mol Cell Biol.} 2018\relax }}{23}{figure.caption.25}\protected@file@percent }
\newlabel{fig:cohesin}{{2.3}{23}{Soutourina\emph {, Nature Review Mol Cell Biol.} 2018\relax }{figure.caption.25}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.4}{\ignorespaces Allen and Taatjes, \emph  {Nature Reviews Mol Cell Biol}. 2015\relax }}{24}{figure.caption.26}\protected@file@percent }
\newlabel{fig:cdk9}{{2.4}{24}{Allen and Taatjes, \emph {Nature Reviews Mol Cell Biol}. 2015\relax }{figure.caption.26}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.5}{\ignorespaces Bugter et al. \emph  {, Nature Review Cancer}, 2021\relax }}{24}{figure.caption.27}\protected@file@percent }
\newlabel{fig:wnt}{{2.5}{24}{Bugter et al. \emph {, Nature Review Cancer}, 2021\relax }{figure.caption.27}{}}
\@writefile{toc}{\contentsline {section}{\numberline {2.2}Wnt signalling pathway}{24}{section.2.2}\protected@file@percent }
\newlabel{wnt-signalling-pathway}{{2.2}{24}{Wnt signalling pathway}{section.2.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.6}{\ignorespaces Bugter et al. \emph  {, Nature Review Cancer}, 2021\relax }}{25}{figure.caption.28}\protected@file@percent }
\newlabel{fig:negative}{{2.6}{25}{Bugter et al. \emph {, Nature Review Cancer}, 2021\relax }{figure.caption.28}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.2.1}$\beta $-catenin structure}{25}{subsection.2.2.1}\protected@file@percent }
\newlabel{ux3b2-catenin-structure}{{2.2.1}{25}{$\beta $-catenin structure}{subsection.2.2.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.7}{\ignorespaces Valenta \emph  {et al., EMBO J.} 2012\relax }}{26}{figure.caption.29}\protected@file@percent }
\newlabel{fig:CTTA}{{2.7}{26}{Valenta \emph {et al., EMBO J.} 2012\relax }{figure.caption.29}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.8}{\ignorespaces McDonald \emph  {et al., Dev Cell}, 2009\relax }}{26}{figure.caption.29}\protected@file@percent }
\newlabel{fig:domains}{{2.8}{26}{McDonald \emph {et al., Dev Cell}, 2009\relax }{figure.caption.29}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.2.2}The canonical Wnt $\beta $-catenin pathway is crucially involved in colorectal cancer}{26}{subsection.2.2.2}\protected@file@percent }
\newlabel{the-canonical-wntux3b2-catenin-pathway-is-crucially-involved-in-colorectal-cancer}{{2.2.2}{26}{The canonical Wnt $\beta $-catenin pathway is crucially involved in colorectal cancer}{subsection.2.2.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.9}{\ignorespaces Firestein \emph  {et al., Nature} 2008\relax }}{27}{figure.caption.30}\protected@file@percent }
\newlabel{fig:histo}{{2.9}{27}{Firestein \emph {et al., Nature} 2008\relax }{figure.caption.30}{}}
\@writefile{toc}{\contentsline {section}{\numberline {2.3}CBP/p300}{27}{section.2.3}\protected@file@percent }
\newlabel{cbpp300}{{2.3}{27}{CBP/p300}{section.2.3}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.3.1}CBP/p300 structure}{27}{subsection.2.3.1}\protected@file@percent }
\newlabel{crepp300-structure}{{2.3.1}{27}{CBP/p300 structure}{subsection.2.3.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.10}{\ignorespaces Wang \emph  {et al., Cell Mol Life Sci.} 2013\relax }}{28}{figure.caption.31}\protected@file@percent }
\newlabel{fig:cbp_domain}{{2.10}{28}{Wang \emph {et al., Cell Mol Life Sci.} 2013\relax }{figure.caption.31}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.11}{\ignorespaces CBP/p300 regulate cell cycle at multiple time points\relax }}{29}{figure.caption.32}\protected@file@percent }
\newlabel{fig:cycle}{{2.11}{29}{CBP/p300 regulate cell cycle at multiple time points\relax }{figure.caption.32}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.3.2}CBP/p300 in cancer}{29}{subsection.2.3.2}\protected@file@percent }
\newlabel{crepp300-in-cancer}{{2.3.2}{29}{CBP/p300 in cancer}{subsection.2.3.2}{}}
\@writefile{toc}{\contentsline {section}{\numberline {2.4}TSSa-RNAs transcription}{29}{section.2.4}\protected@file@percent }
\newlabel{tssa-rnas-transcription}{{2.4}{29}{TSSa-RNAs transcription}{section.2.4}{}}
\@writefile{toc}{\contentsline {section}{\numberline {2.5}Enhancers}{30}{section.2.5}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.5.1}Properties of eRNAs}{31}{subsection.2.5.1}\protected@file@percent }
\newlabel{properties-of-ernas}{{2.5.1}{31}{Properties of eRNAs}{subsection.2.5.1}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.5.2}eRNAs proposed functions}{31}{subsection.2.5.2}\protected@file@percent }
\newlabel{ernas-proposed-functions}{{2.5.2}{31}{eRNAs proposed functions}{subsection.2.5.2}{}}
\@writefile{toc}{\contentsline {section}{\numberline {2.6}Assessing whether the CRC 8q24 risk region acts as an enhancer}{31}{section.2.6}\protected@file@percent }
\newlabel{assessing-whether-the-crc-8q24-risk-region-acts-as-an-enhancer}{{2.6}{31}{Assessing whether the CRC 8q24 risk region acts as an enhancer}{section.2.6}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.12}{\ignorespaces Studniarek \emph  {et al., Trends in Genetics,} 2021\relax }}{32}{figure.caption.33}\protected@file@percent }
\newlabel{fig:functions}{{2.12}{32}{Studniarek \emph {et al., Trends in Genetics,} 2021\relax }{figure.caption.33}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.13}{\ignorespaces Tuupanen et al, Nat Genet, 2009\relax }}{33}{figure.caption.34}\protected@file@percent }
\newlabel{fig:rs1}{{2.13}{33}{Tuupanen et al, Nat Genet, 2009\relax }{figure.caption.34}{}}
\@writefile{toc}{\contentsline {section}{\numberline {2.7}The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling}{33}{section.2.7}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.14}{\ignorespaces Tuupanen et al, Nat Genet, 2009\relax }}{34}{figure.caption.35}\protected@file@percent }
\newlabel{fig:rs2}{{2.14}{34}{Tuupanen et al, Nat Genet, 2009\relax }{figure.caption.35}{}}
\@writefile{toc}{\contentsline {section}{\numberline {2.8}CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instabilty in colon cancer}{34}{section.2.8}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.15}{\ignorespaces Ling et al, Cold Springer, 2022\relax }}{36}{figure.caption.36}\protected@file@percent }
\@writefile{toc}{\contentsline {chapter}{\numberline {3}Chromosome domains and oncogene activation}{37}{chapter.3}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {3.1}Genome organization and transcription regulation}{37}{section.3.1}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {3.1.1}CTCF}{37}{subsection.3.1.1}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.1}{\ignorespaces Yatskevich et al., Annu Rev Genet. 2019\relax }}{38}{figure.caption.37}\protected@file@percent }
\newlabel{fig:chip}{{3.1}{38}{Yatskevich et al., Annu Rev Genet. 2019\relax }{figure.caption.37}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.1.2}Cohesin mediates transcriptional insulation by CCCTC-binding factor}{38}{subsection.3.1.2}\protected@file@percent }
\newlabel{cohesin-mediates-transcriptional-insulation-by-ccctc-binding-factor}{{3.1.2}{38}{Cohesin mediates transcriptional insulation by CCCTC-binding factor}{subsection.3.1.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.2}{\ignorespaces Wendt et al, Nature, 2008\relax }}{39}{figure.caption.38}\protected@file@percent }
\newlabel{fig:rep}{{3.2}{39}{Wendt et al, Nature, 2008\relax }{figure.caption.38}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.3}{\ignorespaces Herold \emph  {et al., Development,} 2012\relax }}{39}{figure.caption.39}\protected@file@percent }
\newlabel{fig:chrom}{{3.3}{39}{Herold \emph {et al., Development,} 2012\relax }{figure.caption.39}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.4}{\ignorespaces Parelho et al, Cell, 2008\relax }}{39}{figure.caption.39}\protected@file@percent }
\newlabel{fig:cohe}{{3.4}{39}{Parelho et al, Cell, 2008\relax }{figure.caption.39}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.5}{\ignorespaces Merkenschlager and Nora, Ann Rev Gen Hum Genetics, 2016\relax }}{40}{figure.caption.40}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {3.1.3}CTCF and Cohesin in Genome Folding and Transcriptional Gene Regulation}{40}{subsection.3.1.3}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.6}{\ignorespaces Merkenschlager and Nora, Ann Rev Gen Hum Genetics, 2016\relax }}{41}{figure.caption.41}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {3.2}Chromosome Conformation Capture (3C)}{41}{section.3.2}\protected@file@percent }
\newlabel{chromosome-conformation-capture-3c}{{3.2}{41}{Chromosome Conformation Capture (3C)}{section.3.2}{}}
\@writefile{toc}{\contentsline {section}{\numberline {3.3}Hi-C approach}{41}{section.3.3}\protected@file@percent }
\newlabel{hi-c-approach}{{3.3}{41}{Hi-C approach}{section.3.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.7}{\ignorespaces Lieberma-Aiden \emph  {et al., Science} 2009\relax }}{42}{figure.caption.42}\protected@file@percent }
\newlabel{fig:int}{{3.7}{42}{Lieberma-Aiden \emph {et al., Science} 2009\relax }{figure.caption.42}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.8}{\ignorespaces Lieberma-Aiden \emph  {et al., Science} 2009\relax }}{43}{figure.caption.43}\protected@file@percent }
\newlabel{fig:fish}{{3.8}{43}{Lieberma-Aiden \emph {et al., Science} 2009\relax }{figure.caption.43}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.3.1}Optimization of Hi-C approach}{43}{subsection.3.3.1}\protected@file@percent }
\newlabel{optimization-of-hi-c-approach}{{3.3.1}{43}{Optimization of Hi-C approach}{subsection.3.3.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.9}{\ignorespaces \relax }}{43}{figure.caption.44}\protected@file@percent }
\newlabel{fig:kb}{{3.9}{43}{\relax }{figure.caption.44}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.10}{\ignorespaces \relax }}{43}{figure.caption.44}\protected@file@percent }
\newlabel{fig:sub}{{3.10}{43}{\relax }{figure.caption.44}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.11}{\ignorespaces Rowley and Corces, \emph  {Nature Rev Genetics} 2018\relax }}{44}{figure.caption.45}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.12}{\ignorespaces Dixon \emph  {et al., Mol Cell.} 2016\relax }}{44}{figure.caption.46}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {3.4}Mediator and cohesin connect gene expression and chromatin architecture}{45}{section.3.4}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.13}{\ignorespaces Sun et al., 2019\relax }}{46}{figure.caption.47}\protected@file@percent }
\newlabel{fig:mouse}{{3.13}{46}{Sun et al., 2019\relax }{figure.caption.47}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.4.1}Promoter-Enhancer Communication Occurs Primarily within Insulated neighbourhoods}{46}{subsection.3.4.1}\protected@file@percent }
\newlabel{promoter-enhancer-communication-occurs-primarily-within-insulated-neighbourhoods}{{3.4.1}{46}{Promoter-Enhancer Communication Occurs Primarily within Insulated neighbourhoods}{subsection.3.4.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.14}{\ignorespaces Hnisz et al., Cell, 2016\relax }}{47}{figure.caption.48}\protected@file@percent }
\newlabel{fig:proto}{{3.14}{47}{Hnisz et al., Cell, 2016\relax }{figure.caption.48}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.4.2}Depletion of Mediator causes loss of PIC assembly}{47}{subsection.3.4.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.15}{\ignorespaces Hnisz et al., Cell, 2016\relax }}{47}{figure.caption.49}\protected@file@percent }
\newlabel{fig:cas}{{3.15}{47}{Hnisz et al., Cell, 2016\relax }{figure.caption.49}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.16}{\ignorespaces Hnisz et al., Cell, 2016\relax }}{47}{figure.caption.49}\protected@file@percent }
\newlabel{fig:tal1}{{3.16}{47}{Hnisz et al., Cell, 2016\relax }{figure.caption.49}{}}
\@writefile{toc}{\contentsline {section}{\numberline {3.5}Super-enhancers}{48}{section.3.5}\protected@file@percent }
\newlabel{super-enhancers}{{3.5}{48}{Super-enhancers}{section.3.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.17}{\ignorespaces \relax }}{48}{figure.caption.50}\protected@file@percent }
\newlabel{fig:hema}{{3.17}{48}{\relax }{figure.caption.50}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.18}{\ignorespaces \relax }}{48}{figure.caption.50}\protected@file@percent }
\newlabel{fig:talju}{{3.18}{48}{\relax }{figure.caption.50}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.5.1}How is a SE generated during tumorigenesis?}{49}{subsection.3.5.1}\protected@file@percent }
\newlabel{how-is-a-se-generated-during-tumorigenesis}{{3.5.1}{49}{How is a SE generated during tumorigenesis?}{subsection.3.5.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.19}{\ignorespaces \relax }}{49}{figure.caption.51}\protected@file@percent }
\newlabel{fig:deltal}{{3.19}{49}{\relax }{figure.caption.51}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.20}{\ignorespaces \relax }}{49}{figure.caption.51}\protected@file@percent }
\newlabel{fig:sup}{{3.20}{49}{\relax }{figure.caption.51}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.5.2}How cancer cells take advantage of super-enhancers}{49}{subsection.3.5.2}\protected@file@percent }
\newlabel{how-cancer-cells-take-advantage-of-super-enhancers}{{3.5.2}{49}{How cancer cells take advantage of super-enhancers}{subsection.3.5.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.21}{\ignorespaces \relax }}{50}{figure.caption.52}\protected@file@percent }
\newlabel{fig:study}{{3.21}{50}{\relax }{figure.caption.52}{}}
\@writefile{toc}{\contentsline {section}{\numberline {3.6}The role of MYC in cancer cells}{50}{section.3.6}\protected@file@percent }
\newlabel{the-role-of-myc-in-cancer-cells}{{3.6}{50}{The role of MYC in cancer cells}{section.3.6}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.22}{\ignorespaces Deletion of both Myc and APC from small intenstine cells\relax }}{51}{figure.caption.53}\protected@file@percent }
\newlabel{fig:inhi}{{3.22}{51}{Deletion of both Myc and APC from small intenstine cells\relax }{figure.caption.53}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.23}{\ignorespaces Gabai et al., CSHL 2014\relax }}{51}{figure.caption.54}\protected@file@percent }
\newlabel{fig:key}{{3.23}{51}{Gabai et al., CSHL 2014\relax }{figure.caption.54}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.6.1}Key aspects of MYC in tumorigenesis}{51}{subsection.3.6.1}\protected@file@percent }
\newlabel{key-aspect-of-myc-in-tumorigenesis}{{3.6.1}{51}{Key aspects of MYC in tumorigenesis}{subsection.3.6.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.6.1.1}MYC transcription factor forms a heterodimer with MAX}{51}{subsubsection.3.6.1.1}\protected@file@percent }
\newlabel{myc-transcription-factor-forms-a-heterodimer-with-max}{{3.6.1.1}{51}{MYC transcription factor forms a heterodimer with MAX}{subsubsection.3.6.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.24}{\ignorespaces  MYC is a transcription factor forming a heterodimer with MAX\relax }}{52}{figure.caption.55}\protected@file@percent }
\newlabel{fig:myc}{{3.24}{52}{MYC is a transcription factor forming a heterodimer with MAX\relax }{figure.caption.55}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.25}{\ignorespaces Carroll et al., Front.Med. 2018\relax }}{52}{figure.caption.56}\protected@file@percent }
\newlabel{fig:maxmyc}{{3.25}{52}{Carroll et al., Front.Med. 2018\relax }{figure.caption.56}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.26}{\ignorespaces Lourenco et al., Nature Reviews Cancer, 2021\relax }}{52}{figure.caption.56}\protected@file@percent }
\newlabel{fig:regmyc}{{3.26}{52}{Lourenco et al., Nature Reviews Cancer, 2021\relax }{figure.caption.56}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.6.2}By which major mechanism or pathway do MYC proteins promote tumorigenesis?}{52}{subsection.3.6.2}\protected@file@percent }
\newlabel{by-which-major-mechanism-or-pathway-myc-proteins-promote-tumorigenesis}{{3.6.2}{52}{By which major mechanism or pathway do MYC proteins promote tumorigenesis?}{subsection.3.6.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.27}{\ignorespaces Lourenco et al., Nature Reviews Cancer, 2021\relax }}{53}{figure.caption.57}\protected@file@percent }
\newlabel{fig:ppmyc}{{3.27}{53}{Lourenco et al., Nature Reviews Cancer, 2021\relax }{figure.caption.57}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.28}{\ignorespaces Kress et al, NatureRevCancer-2015\relax }}{53}{figure.caption.58}\protected@file@percent }
\newlabel{fig:ppmyc}{{3.28}{53}{Kress et al, NatureRevCancer-2015\relax }{figure.caption.58}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {4}Targeting transcription in cancer}{55}{chapter.4}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {4.1}Age-related remodellling of oesophageal epithelia by mutated cancer drivers}{55}{section.4.1}\protected@file@percent }
\newlabel{age-related-remodellling-of-oesophageal-epithelia-by-mutated-cancer-drivers}{{4.1}{55}{Age-related remodellling of oesophageal epithelia by mutated cancer drivers}{section.4.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.1}{\ignorespaces Yokoyama et al., Nature 2019\relax }}{55}{figure.caption.59}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.2}{\ignorespaces Yokoyama et al., Nature 2019\relax }}{56}{figure.caption.60}\protected@file@percent }
\newlabel{fig:mosaic}{{4.2}{56}{Yokoyama et al., Nature 2019\relax }{figure.caption.60}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.3}{\ignorespaces Yokoyama et al., Nature 2019\relax }}{56}{figure.caption.61}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {4.2}The risk of suffering any cancer increases during aging}{57}{section.4.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.4}{\ignorespaces Screen Shot 2022-11-04 at 11.25.54.png\relax }}{58}{figure.caption.62}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {4.3}Targeted therapeutics generally lead to resistance}{58}{section.4.3}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {4.3.1}Mutations in cancer}{58}{subsection.4.3.1}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.5}{\ignorespaces Gonda and Ramsay, \emph  {Nature Review Mol Cell Biology}, 2015\relax }}{59}{figure.caption.63}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {4.4}Target transcription in cancer}{59}{section.4.4}\protected@file@percent }
\newlabel{target-transcription-in-cancer}{{4.4}{59}{Target transcription in cancer}{section.4.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.6}{\ignorespaces Bywater \emph  {et al., Nature Review Cancer-} 2013\relax }}{60}{figure.caption.64}\protected@file@percent }
\newlabel{fig:protac}{{4.6}{60}{Bywater \emph {et al., Nature Review Cancer-} 2013\relax }{figure.caption.64}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.7}{\ignorespaces \relax }}{61}{figure.caption.65}\protected@file@percent }
\newlabel{fig:brd4}{{4.7}{61}{\relax }{figure.caption.65}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.5}BRD4}{61}{section.4.5}\protected@file@percent }
\newlabel{brd4}{{4.5}{61}{BRD4}{section.4.5}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.5.1}Selective inhibition of Tumor Oncogenes by Disruption of Super-Enhancers}{61}{subsection.4.5.1}\protected@file@percent }
\newlabel{selective-inhibition-of-tumor-oncogenes-by-disruption-of-super-enhancers}{{4.5.1}{61}{Selective inhibition of Tumor Oncogenes by Disruption of Super-Enhancers}{subsection.4.5.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.8}{\ignorespaces \relax }}{62}{figure.caption.66}\protected@file@percent }
\newlabel{fig:yaptaz}{{4.8}{62}{\relax }{figure.caption.66}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.6}YAP/TAZ}{62}{section.4.6}\protected@file@percent }
\newlabel{yaptaz}{{4.6}{62}{YAP/TAZ}{section.4.6}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.9}{\ignorespaces \relax }}{62}{figure.caption.67}\protected@file@percent }
\newlabel{fig:hippo}{{4.9}{62}{\relax }{figure.caption.67}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.10}{\ignorespaces Dupont et al., Nature 2011\relax }}{62}{figure.caption.67}\protected@file@percent }
\newlabel{fig:ecm}{{4.10}{62}{Dupont et al., Nature 2011\relax }{figure.caption.67}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.11}{\ignorespaces \relax }}{63}{figure.caption.68}\protected@file@percent }
\newlabel{fig:tead}{{4.11}{63}{\relax }{figure.caption.68}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.7}TEAD}{63}{section.4.7}\protected@file@percent }
\newlabel{tead}{{4.7}{63}{TEAD}{section.4.7}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.7.1}YAP/TAZ/TEAD}{63}{subsection.4.7.1}\protected@file@percent }
\newlabel{yaptaztead}{{4.7.1}{63}{YAP/TAZ/TEAD}{subsection.4.7.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.8}Nuclear receptors}{64}{section.4.8}\protected@file@percent }
\newlabel{nuclear-receptors}{{4.8}{64}{Nuclear receptors}{section.4.8}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.12}{\ignorespaces \relax }}{65}{figure.caption.69}\protected@file@percent }
\newlabel{fig:canyt}{{4.12}{65}{\relax }{figure.caption.69}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.8.1}Estrogen receptor \(\alpha \)}{65}{subsection.4.8.1}\protected@file@percent }
\newlabel{estrogen-receptor-alpha}{{4.8.1}{65}{\texorpdfstring {Estrogen receptor \(\alpha \)}{Estrogen receptor \textbackslash alpha}}{subsection.4.8.1}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.8.2}ER$\alpha $ in breast cancer}{65}{subsection.4.8.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.13}{\ignorespaces Bushweller, Nature Review Cancer 2019\relax }}{66}{figure.caption.70}\protected@file@percent }
\newlabel{fig:serm}{{4.13}{66}{Bushweller, Nature Review Cancer 2019\relax }{figure.caption.70}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.14}{\ignorespaces \relax }}{66}{figure.caption.71}\protected@file@percent }
\newlabel{fig:strategies}{{4.14}{66}{\relax }{figure.caption.71}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.8.2.1}Mechanisms provoking breast cancer drug resistance}{67}{subsubsection.4.8.2.1}\protected@file@percent }
\newlabel{mechanisms-provoking-breast-cancer-drug-resistance}{{4.8.2.1}{67}{Mechanisms provoking breast cancer drug resistance}{subsubsection.4.8.2.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.8.2.2}Summary}{67}{subsubsection.4.8.2.2}\protected@file@percent }
\newlabel{summary}{{4.8.2.2}{67}{Summary}{subsubsection.4.8.2.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.15}{\ignorespaces Screen Shot 2022-11-18 at 11-59-02.png\relax }}{68}{figure.caption.72}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.8.2.3}ER$\alpha $ transcriptional program}{68}{subsubsection.4.8.2.3}\protected@file@percent }
\newlabel{ertranscriptional-program}{{4.8.2.3}{68}{\texorpdfstring {ER$\alpha $ transcriptional program}{ERtranscriptional program}}{subsubsection.4.8.2.3}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {5}Genome instability and DNA damage response and repair}{70}{chapter.5}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {5.1}R-loops}{70}{section.5.1}\protected@file@percent }
\newlabel{r-loops}{{5.1}{70}{R-loops}{section.5.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.1}{\ignorespaces Hamperl and Cimprich, DNA Repair, 2014\relax }}{70}{figure.caption.73}\protected@file@percent }
\newlabel{fig:hybrid}{{5.1}{70}{Hamperl and Cimprich, DNA Repair, 2014\relax }{figure.caption.73}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.1.1}R-loop degradation}{71}{subsection.5.1.1}\protected@file@percent }
\newlabel{r-loop-degradation}{{5.1.1}{71}{R-loop degradation}{subsection.5.1.1}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.1.2}R-loop recognition and distribution}{71}{subsection.5.1.2}\protected@file@percent }
\newlabel{r-loop-recognition-and-distribution}{{5.1.2}{71}{R-loop recognition and distribution}{subsection.5.1.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.2}{\ignorespaces \relax }}{72}{figure.caption.74}\protected@file@percent }
\newlabel{fig:vim}{{5.2}{72}{\relax }{figure.caption.74}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.1.3}VIM-antisense1}{72}{subsection.5.1.3}\protected@file@percent }
\newlabel{vim-antisense1}{{5.1.3}{72}{VIM-antisense1}{subsection.5.1.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.3}{\ignorespaces \relax }}{73}{figure.caption.75}\protected@file@percent }
\newlabel{fig:hottip}{{5.3}{73}{\relax }{figure.caption.75}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.1.4}HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia}{73}{subsection.5.1.4}\protected@file@percent }
\newlabel{hottip-dependent-r-loop-formation-regulates-ctcf-boundary-activity-and-tad-integrity-in-leukemia}{{5.1.4}{73}{HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia}{subsection.5.1.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.4}{\ignorespaces Base excision repair\relax }}{75}{figure.caption.76}\protected@file@percent }
\newlabel{fig:ber}{{5.4}{75}{Base excision repair\relax }{figure.caption.76}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.1.5}HOTTIP lncRNA Promotes Hematopoietic Stem Cells Self-Renewal Leading to AML-like Disease in Mice}{75}{subsection.5.1.5}\protected@file@percent }
\newlabel{hottip-lncrna-promotes-hematopoietic-stem-cells-self-renewal-leading-to-aml-like-disease-in-mice}{{5.1.5}{75}{HOTTIP lncRNA Promotes Hematopoietic Stem Cells Self-Renewal Leading to AML-like Disease in Mice}{subsection.5.1.5}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.2}DNA damage}{75}{section.5.2}\protected@file@percent }
\newlabel{dna-damage}{{5.2}{75}{DNA damage}{section.5.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.5}{\ignorespaces R loop repair\relax }}{76}{figure.caption.77}\protected@file@percent }
\newlabel{fig:rrep}{{5.5}{76}{R loop repair\relax }{figure.caption.77}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.3}R loop modified bases}{76}{section.5.3}\protected@file@percent }
\newlabel{r-loop-modified-bases}{{5.3}{76}{R loop modified bases}{section.5.3}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.3.1}Apical kinases}{76}{subsection.5.3.1}\protected@file@percent }
\newlabel{apical-kinases}{{5.3.1}{76}{Apical kinases}{subsection.5.3.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.6}{\ignorespaces Apical kinases\relax }}{77}{figure.caption.78}\protected@file@percent }
\newlabel{fig:apical}{{5.6}{77}{Apical kinases\relax }{figure.caption.78}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.7}{\ignorespaces Blackford and Jackson, \emph  {Mol Cell}, 2017\relax }}{78}{figure.caption.79}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {5.8}{\ignorespaces Trenner and Satori, Frontiers in Oncology 2019\relax }}{78}{figure.caption.80}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {5.9}{\ignorespaces Screen Shot 2022-11-30 at 10-03-17.png\relax }}{79}{figure.caption.81}\protected@file@percent }
\newlabel{fig:biot}{{5.9}{79}{Screen Shot 2022-11-30 at 10-03-17.png\relax }{figure.caption.81}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.3.2}Topoisomerases}{79}{subsection.5.3.2}\protected@file@percent }
\newlabel{topoisomerases}{{5.3.2}{79}{Topoisomerases}{subsection.5.3.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.3.2.1}A topoisomerase IIb-mediated dsDNA break required for Regulated Transcription}{79}{subsubsection.5.3.2.1}\protected@file@percent }
\newlabel{a-topoisomerase-iib-mediated-dsdna-break-required-for-regulated-transcription}{{5.3.2.1}{79}{A topoisomerase IIb-mediated dsDNA break required for Regulated Transcription}{subsubsection.5.3.2.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.3.2.2}BRCA1}{80}{subsubsection.5.3.2.2}\protected@file@percent }
\newlabel{brca1}{{5.3.2.2}{80}{BRCA1}{subsubsection.5.3.2.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.3.2.3}Stark et al.}{80}{subsubsection.5.3.2.3}\protected@file@percent }
\newlabel{stark-et-al.}{{5.3.2.3}{80}{Stark et al}{subsubsection.5.3.2.3}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.4}DNA damage signaling activation during tumorigenesis}{81}{section.5.4}\protected@file@percent }
\newlabel{dna-damage-signaling-activation-during-tumorigenesis}{{5.4}{81}{DNA damage signaling activation during tumorigenesis}{section.5.4}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.4.1}Which tumorigenic events trigger activation DDR?}{81}{subsection.5.4.1}\protected@file@percent }
\newlabel{which-tumorigenic-events-trigger-activation-ddr-very-early-in-tumorigenesis}{{5.4.1}{81}{Which tumorigenic events trigger activation DDR?}{subsection.5.4.1}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.4.2}Oncogene induced senescence cells}{81}{subsection.5.4.2}\protected@file@percent }
\newlabel{oncogene-induced-senescence-cells}{{5.4.2}{81}{Oncogene induced senescence cells}{subsection.5.4.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.4.2.1}Replication stress}{82}{subsubsection.5.4.2.1}\protected@file@percent }
\newlabel{replication-stress}{{5.4.2.1}{82}{Replication stress}{subsubsection.5.4.2.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.4.2.2}Chromosome abnormalities due to pre-mitotic defects are frequently found in tumors}{82}{subsubsection.5.4.2.2}\protected@file@percent }
\newlabel{chromosome-abnormalities-due-to-pre-mitotic-defects-are-frequently-found-in-tumors}{{5.4.2.2}{82}{Chromosome abnormalities due to pre-mitotic defects are frequently found in tumors}{subsubsection.5.4.2.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.4.2.3}Transcription replication conflicts}{83}{subsubsection.5.4.2.3}\protected@file@percent }
\newlabel{transcription-replication-conflicts}{{5.4.2.3}{83}{Transcription replication conflicts}{subsubsection.5.4.2.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.4.2.4}Increased global transcription activity as a mechanism of replication stress in cancer}{83}{subsubsection.5.4.2.4}\protected@file@percent }
\newlabel{increased-global-transcription-activity-as-a-mechanism-of-replication-stress-in-cancer}{{5.4.2.4}{83}{Increased global transcription activity as a mechanism of replication stress in cancer}{subsubsection.5.4.2.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.10}{\ignorespaces Francia \emph  {et al., Nature} 2012\relax }}{84}{figure.caption.82}\protected@file@percent }
\newlabel{fig:hnf}{{5.10}{84}{Francia \emph {et al., Nature} 2012\relax }{figure.caption.82}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.5}Biogenesis of canonical miRNA}{84}{section.5.5}\protected@file@percent }
\newlabel{biogenesis-of-canonical-mirna}{{5.5}{84}{Biogenesis of canonical miRNA}{section.5.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.11}{\ignorespaces Francia \emph  {et al., Nature} 2012\relax }}{85}{figure.caption.83}\protected@file@percent }
\newlabel{fig:si}{{5.11}{85}{Francia \emph {et al., Nature} 2012\relax }{figure.caption.83}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.6}DICER and DROSHA regulation of DDR and checkpoint enforcement}{85}{section.5.6}\protected@file@percent }
\newlabel{dicer-and-drosh-regulation-of-ddr-and-checkpoint-enforcement}{{5.6}{85}{DICER and DROSHA regulation of DDR and checkpoint enforcement}{section.5.6}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.12}{\ignorespaces Francia \emph  {et al., Nature} 2012\relax }}{86}{figure.caption.84}\protected@file@percent }
\newlabel{fig:lac}{{5.12}{86}{Francia \emph {et al., Nature} 2012\relax }{figure.caption.84}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.13}{\ignorespaces Michelini \emph  {et al., Nature Cell Biology} 2017\relax }}{86}{figure.caption.85}\protected@file@percent }
\newlabel{fig:dd1}{{5.13}{86}{Michelini \emph {et al., Nature Cell Biology} 2017\relax }{figure.caption.85}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.7}DDRNAs}{86}{section.5.7}\protected@file@percent }
\newlabel{ddrnas}{{5.7}{86}{DDRNAs}{section.5.7}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.14}{\ignorespaces Michelini \emph  {et al., Nature Cell Biology} 2017\relax }}{87}{figure.caption.86}\protected@file@percent }
\newlabel{fig:dd2}{{5.14}{87}{Michelini \emph {et al., Nature Cell Biology} 2017\relax }{figure.caption.86}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.7.1}DDRNAs and dilncRNAs regulate DDR and DNA repair}{87}{subsection.5.7.1}\protected@file@percent }
\newlabel{ddrnas-and-dilncrnas-regulate-ddr-and-dna-repair}{{5.7.1}{87}{DDRNAs and dilncRNAs regulate DDR and DNA repair}{subsection.5.7.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.8}RNA Pol II recruitment at DSBs}{87}{section.5.8}\protected@file@percent }
\newlabel{rna-pol-ii-recruitment-at-dsbs}{{5.8}{87}{RNA Pol II recruitment at DSBs}{section.5.8}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.15}{\ignorespaces Michelini \emph  {et al., Nature Cell Biology} 2017\relax }}{88}{figure.caption.87}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {5.16}{\ignorespaces Michelini \emph  {et al., Nature Cell Biology} 2017\relax }}{88}{figure.caption.88}\protected@file@percent }
\@writefile{toc}{\contentsline {chapter}{\numberline {6}Telomeres and telomere transcription in cancer}{89}{chapter.6}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {6.1}What are telomeres?}{89}{section.6.1}\protected@file@percent }
\newlabel{what-are-telomeres}{{6.1}{89}{What are telomeres?}{section.6.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {6.2}Telomeres mask chromosome ends from being recognized as double-strand breaks}{89}{section.6.2}\protected@file@percent }
\newlabel{telomeres-mask-chromosome-ends-from-being-recognized-as-double-strand-breaks}{{6.2}{89}{Telomeres mask chromosome ends from being recognized as double-strand breaks}{section.6.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.1}{\ignorespaces Lim and Cech, Nature Reviews Mol Cell Biol, 2021\relax }}{90}{figure.caption.89}\protected@file@percent }
\newlabel{fig:shelt}{{6.1}{90}{Lim and Cech, Nature Reviews Mol Cell Biol, 2021\relax }{figure.caption.89}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.2}{\ignorespaces Cesare \emph  {et al., Mol Cell} 2013\relax }}{90}{figure.caption.90}\protected@file@percent }
\newlabel{fig:ends}{{6.2}{90}{Cesare \emph {et al., Mol Cell} 2013\relax }{figure.caption.90}{}}
\@writefile{toc}{\contentsline {section}{\numberline {6.3}Telomere dysfunction in a p53 and Rb mutant setting does not induce cell cycle block}{90}{section.6.3}\protected@file@percent }
\newlabel{telomere-dysfunction-in-a-p53-and-rb-mutant-setting-does-not-induce-cell-cycle-block}{{6.3}{90}{Telomere dysfunction in a p53 and Rb mutant setting does not induce cell cycle block}{section.6.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.3}{\ignorespaces \relax }}{91}{figure.caption.91}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.4}{\ignorespaces Doksani \& de Lange. \emph  {Cold Spring Harbor Press.} 2014 Nature Reviews Cancer, 2008\relax }}{91}{figure.caption.92}\protected@file@percent }
\newlabel{fig:bsh}{{6.4}{91}{Doksani \& de Lange. \emph {Cold Spring Harbor Press.} 2014 Nature Reviews Cancer, 2008\relax }{figure.caption.92}{}}
\@writefile{toc}{\contentsline {section}{\numberline {6.4}End of replication problem}{91}{section.6.4}\protected@file@percent }
\newlabel{end-of-replication-problem}{{6.4}{91}{End of replication problem}{section.6.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.5}{\ignorespaces \relax }}{92}{figure.caption.93}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {6.4.1}Hayflick limit}{92}{subsection.6.4.1}\protected@file@percent }
\newlabel{hayflick-limit}{{6.4.1}{92}{Hayflick limit}{subsection.6.4.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.6}{\ignorespaces Stewart \& Weinberg. Ann Rev Cell Dev Biol, 2006\relax }}{93}{figure.caption.94}\protected@file@percent }
\newlabel{fig:crisis}{{6.6}{93}{Stewart \& Weinberg. Ann Rev Cell Dev Biol, 2006\relax }{figure.caption.94}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {6.4.2}Triggering senescence}{93}{subsection.6.4.2}\protected@file@percent }
\newlabel{triggering-senescence}{{6.4.2}{93}{Triggering senescence}{subsection.6.4.2}{}}
\@writefile{toc}{\contentsline {section}{\numberline {6.5}Cell crisis}{93}{section.6.5}\protected@file@percent }
\newlabel{cell-crisis}{{6.5}{93}{Cell crisis}{section.6.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.7}{\ignorespaces \relax }}{94}{figure.caption.95}\protected@file@percent }
\newlabel{fig:temp}{{6.7}{94}{\relax }{figure.caption.95}{}}
\@writefile{toc}{\contentsline {section}{\numberline {6.6}Telomerase enzyme}{94}{section.6.6}\protected@file@percent }
\newlabel{telomerase-enzyme}{{6.6}{94}{Telomerase enzyme}{section.6.6}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.8}{\ignorespaces \relax }}{95}{figure.caption.96}\protected@file@percent }
\newlabel{fig:recr}{{6.8}{95}{\relax }{figure.caption.96}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {6.6.1}Usage of telomerase}{95}{subsection.6.6.1}\protected@file@percent }
\newlabel{usage-of-telomerase}{{6.6.1}{95}{Usage of telomerase}{subsection.6.6.1}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {7}Journal Clubs}{96}{chapter.7}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {7.1}Mechansims of transcription regulation}{96}{section.7.1}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.1.1}Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release}{96}{subsection.7.1.1}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.1.2}SPT5 stabilization of promoter - proximal RNA polymerase II}{97}{subsection.7.1.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.1}{\ignorespaces (A) Schematic depiction of the key steps in the transcription cycle. (B) Proposed hypothetical model of p300/CBP-activity-dependent dynamic enhancer activation. \relax }}{98}{figure.caption.97}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {7.2}Mechanisms of transcription regulation in cancer}{99}{section.7.2}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.2.1}MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation}{99}{subsection.7.2.1}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.2}{\ignorespaces (A) SPT5 stabilizes RNA Pol II during the early elongation stage. With the SPT5 protein (upper panel), once RNA Pol II is initiated and escapes from the promoter, RNA Pol II undergoes productive elongation until termination. Without SPT5 (lower panel), early-elongating RNA Pol II undergoes RPB1 degradation that is mediated by the CUL3 ubiquitin ligase, the VCP unfoldase, and a novel form of the P-TEFb component CDK9. Late-elongating RNA Pol II without SPT5 can persist in transcription at a slower speed. (B) Failure in RNA Pol II passage on the +1 nucleosome leads to 2 distinct pathways to eliminate RNA Pol II from chromatin.\relax }}{100}{figure.caption.98}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.3}{\ignorespaces \relax }}{100}{figure.caption.99}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.2.2}BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer}{101}{subsection.7.2.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.4}{\ignorespaces \relax }}{102}{figure.caption.100}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.2.3}HSF2 cooperates with HSF1 to drive a transcriptional program critical for the malignant state}{103}{subsection.7.2.3}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.5}{\ignorespaces \relax }}{104}{figure.caption.101}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.2.4}Oncogenic lncRNAs alter epigenetic memory at a fragile chromosomal site in human cancer cells}{104}{subsection.7.2.4}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.6}{\ignorespaces Usually, CENP-A associates with its chaperone HJURP to deposit at centromeres. Overexpressed CENP-A in cancer cells possibly form hybrid nucleosomes with H3.3 and hijacks the H3.3 chaperone pathways to deposit ectopically, thus invading regions such as the 8q24 locus and altering the local chromatin landscape. The 8q24-derived oncogenic lncRNAs could serve as a recruitment signal for incorrect chaperone- histone variant complexes. The CENP-A at ectopic sites promotes active transcription of the local chromatin as a feedback mechanism, leading to a higher R-loop level. The R-loop tethered lncRNAs, in turn, could help CENP-A ectopic deposition. Further, the unresolved R-loop configuration with the ectopic CENP-A nucleosomes may impair DNA replication efficiency, resulting in an under-replicated DNA with stalled replication forks. When the cells enter mitosis amid chromosomes with decondensed chro- matin regions, with R-loops and ectopic CENP-A presence, these regions can build a weak ectopic kinetochore, resulting in chromosome breaks during segregation.\relax }}{105}{figure.caption.102}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {7.3}Targeting transcription in cancer}{105}{section.7.3}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.3.1}Targeting histone acetylation dynamics and oncogenic transcription by catalytic p300/CBP inhibition}{105}{subsection.7.3.1}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.7}{\ignorespaces Model for the temporal regulation of gene expression by the histone acetylation-methylation equilibrium and the consequences of KAT inhibition on cellular transcription independent of changes in 3D chromatin configuration.\relax }}{106}{figure.caption.103}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.3.2}Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma}{107}{subsection.7.3.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.8}{\ignorespaces \relax }}{108}{figure.caption.104}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.3.3}Transcription elongation factors represent in vivo cancer dependencies in glioblastoma}{108}{subsection.7.3.3}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {7.4}Nuclear receptors in cancer}{109}{section.7.4}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.4.1}ER$\alpha $ is an RNA-binding protein sustaining tumor cell survival and drug resistance}{109}{subsection.7.4.1}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.9}{\ignorespaces \relax }}{110}{figure.caption.105}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.10}{\ignorespaces \relax }}{111}{figure.caption.106}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.4.2}Analysis of estrogen-regulated enhancer RNAs identified a functional motif required for enhancer assembly and gene expression}{111}{subsection.7.4.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.11}{\ignorespaces \relax }}{113}{figure.caption.107}\protected@file@percent }
